These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24320029)

  • 1. Editorial: Managing the cardiovascular risk associated with the metabolic syndrome.
    Montalto G; Rizzo M; Mikhailidis DP
    Curr Pharm Des; 2014; 20(31):4941-3. PubMed ID: 24320029
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome and the role of the polypill in the prevention of its complications].
    Rosolová H
    Vnitr Lek; 2017; 63(10):712-716. PubMed ID: 29127755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in an Asian Chinese population and agents and targets for cardiovascular protection.
    Fung ML; Wong TM
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):77-8. PubMed ID: 17584041
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
    Santilli F; D'Ardes D; Guagnano MT; Davi G
    Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome: navigating a danger zone of heart risk factors.
    Health After 50 Sci Am Consum Health; 2015 Sep; 27(8):1-2. PubMed ID: 26685336
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndrome.
    Gouni-Berthold I; Berthold HK
    Curr Pharm Des; 2014; 20(31):5025-38. PubMed ID: 24320031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitions of the metabolic syndrome.
    Behre CJ; Fagerberg B
    JAMA; 2003 Mar; 289(10):1240; author reply 1241. PubMed ID: 12633172
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic syndrome and cardiovascular health: a look beyond the horizon.
    Zhang Y; Ren J
    Curr Pharm Des; 2013; 19(27):4797-8. PubMed ID: 23844872
    [No Abstract]   [Full Text] [Related]  

  • 9. Definitions of the metabolic syndrome.
    Unwin N
    JAMA; 2003 Mar; 289(10):1240; author reply 1241. PubMed ID: 12633173
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 8. Asymptomatic hyperuricemia].
    Hosoya T; Ohno I
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):882-9. PubMed ID: 23772502
    [No Abstract]   [Full Text] [Related]  

  • 11. Definitions of the metabolic syndrome.
    Phillips B
    JAMA; 2003 Mar; 289(10):1241; author reply 1241. PubMed ID: 12633170
    [No Abstract]   [Full Text] [Related]  

  • 12. Overactive bladder in men as a marker of cardiometabolic risk.
    Wittert GA; Martin S; Sutherland P; Hall S; Kupelian V; Araujo A
    Med J Aust; 2012 Oct; 197(7):379-80. PubMed ID: 23025729
    [No Abstract]   [Full Text] [Related]  

  • 13. Global risk stratification to improve cardiovascular prevention: integration of traditional risk factors, emerging risk factors, and new, noninvasive cardiovascular imaging.
    Coplan NL; Chernobelsky A
    Am Heart Hosp J; 2005; 3(4):265-8. PubMed ID: 16330920
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel cardiovascular risk biomarkers in metabolic syndrome.
    Montecucco F; Liberale L; Carbone F
    Biomark Med; 2019 Nov; 13(16):1331-1334. PubMed ID: 31599166
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
    Hanna FW
    Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
    [No Abstract]   [Full Text] [Related]  

  • 16. [New targets in patients with cardiometabolic risk].
    Ruilope LM; Carmena R
    Med Clin (Barc); 2007 Oct; 129(15):576-7. PubMed ID: 17988615
    [No Abstract]   [Full Text] [Related]  

  • 17. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolic syndrome in children and adolescents].
    Brandão AP; Brandão AA; Berenson GS; Fuster V
    Arq Bras Cardiol; 2005 Aug; 85(2):79-81. PubMed ID: 16113843
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic kidney disease and the cardiometabolic syndrome.
    Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2006 Aug; 8(8):546-8. PubMed ID: 16896269
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.